What's on the web on your pursuit, hobbies, interests and worries

Hemoglobinuria news

Paroxysmal Nocturnal Hemoglobinuria Treatment Receives Fast Track Designation


Rare Disease Report - Dec 20, 2016
Apellis Pharmaceuticals announced that their orphan drug APL-2, for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) received Fast Track Designation by the FDA. APL-2 is designed for patients who experience hemolysis and require RBC ...
 

Alexion's Phase 1/2 Trial for Paroxysmal Nocturnal Hemoglobinuria Shows Encouraging Results


Rare Disease Report - Dec 5, 2016
During the 2016 American Society of Hematology (ASH) meeting in San Diego, California data from Alexion's Phase 1/2 Trial of ALXN1210 for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) was presented and the early results seem ...
 

Alexion (ALXN) Q4 Earnings: Can the Stock Pull a Surprise?


Zacks.com - Feb 10, 2017
... territories including the U.S., the EU and Japan, driven by a consistently increasing new patient population in both the indications it is approved for - paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS ...
 

Hemoglobinuria - premium items on eBay

NEW Paraoxysmal Nocturnal Hemoglobinuria and Related Disorders


 

NEW Paroxysmal Nocturnal Hemoglobinuria and Related Disorders: Molecular Aspects


 

NEW Paroxysmal Nocturnal Hemoglobinuria and Related Disorders by Hardcover Book


 

>> Go to all great Hemoglobinuria deals on eBay


Hemoglobinuria books

Paraoxysmal Nocturnal Hemoglobinuria and Related Disorders


Few publications focus on the mysterious, genetically acquired disease paroxysmal nocturnal hemoglobinuria (PNH) and the related "intractable" disorders―aplastic anemia and myelodysplastic syndromes. Now, however, the latest understanding of the clinical and molecular genetic aspects of PNH is summarized here in the proceedings of the International Symposium held in Tokyo in 2001. Major topics reviewed include the molecular mechanisms of the PIG-A gene mutation; complement activation and inhibitors; experimental animal models; pathogenesis; the history of PNH research; the natural history of the disease; the mechanism of PNH clone expansion; the emergence of PNH clones under bone marrow failure syndromes; and treatment of the disease by immunosuppressive agents and stem cell transplantation.
>> More info on Amazon

The 2018-2023 World Outlook for Paroxysmal Nocturnal Hemoglobinuria Treatments


by: Icon Group International
This study covers the world outlook for paroxysmal nocturnal hemoglobinuria (PNH) treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created.
>> More info on Amazon

Hemoglobinuria: Webster's Timeline History, 1878 - 2007


by: Icon Group International
Webster's bibliographic and event-based timelines are comprehensive in scope, covering virtually all topics, geographic locations and people. They do so from a linguistic point of view, and in the case of this book, the focus is on "Hemoglobinuria," including when used in literature (e.g. all authors that might have Hemoglobinuria in their name). As such, this book represents the largest compilation of timeline events associated with Hemoglobinuria when it is used in proper noun form. Webster's timelines cover bibliographic citations, patented inventions, as well as non-conventional and alternative meanings which capture ambiguities in usage.
>> More info on Amazon

Paroxysmal Nocturnal Hemoglobinuria and Related Disorders: Molecular Aspects of Pathogenesis


Few publications focus on the mysterious, genetically acquired disease paroxysmal nocturnal hemoglobinuria (PNH) and the related "intractable" disorders―aplastic anemia and myelodysplastic syndromes. Now, however, the latest understanding of the clinical and molecular genetic aspects of PNH is summarized here in the proceedings of the International Symposium held in Tokyo in 2001. Major topics reviewed include the molecular mechanisms of the PIG-A gene mutation; complement activation and inhibitors; experimental animal models; pathogenesis; the history of PNH research; the natural history of the disease; the mechanism of PNH clone expansion; the emergence of PNH clones under bone marrow failure syndromes; and treatment of the disease by immunosuppressive agents and stem cell transplantation.
>> More info on Amazon

>> Go to all Hemoglobinuria books


Hemoglobinuria pictures on the web

>> Show

Hemoglobinuria videos

HEMOGLOBINURIA


POR: HERNANDO CORAL ROSERO M.H.
 

Paroxysmal Nocturnal Hemoglobinuria: Most Important Points


Please visit www.doctorpaul.org for more videos.
 

Hemoglobinuria (Medical Condition)


Symptoms, risk factors and treatments of Hemoglobinuria (Medical Condition) In medicine, hemoglobinuria or haemoglobinuria is a condition in which the ...
 

Paroxysmal Nocturnal Hemoglobinuria


http://usmlefasttrack.com/?p=5629 Paroxysmal, Nocturnal, Hemoglobinuria, Findings, symptoms, findings, causes, mnemonics, review, what is, video, study, ...
 

Hemoglobinuria paroxística Nocturna


4to Curso -Formación temprana de profesores de Inmunología-